Taamil, Ana Jean R.

HRN: 28-71-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/23/2026
03/30/2026
IV
2300mg
Q 6 Hours
PCAP-C
Remove - Pending Acceptance
03/23/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
03/23/2026
03/28/2026
PO
4ml
Q 6 Hours
Oropharyngeal Candidiasis
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: